[Evaluation of the evidence on the HeartMate II and HeartWare ventricular assist devices for the treatment of chronic end-stage heart failure]

Sas G, Boothroyd LJ, Guertin JR, Lambert LJ, Morin JE, Chakor H, Bogaty P
Record ID 32012000859
French
Authors' objectives: The objectives of this evaluation are to: 1. synthesize, by means of a systematic review, the recent evidence (2008-2011) on HeartMate II® (HM II) and HeartWare® (HW), with regard to effectiveness, safety and economic considerations, according to initial indication (bridge to transplantation or permanent "destination" therapy) for patients with end-stage chronic heart failure; and 2. provide an overview, by means of a narrative review, of organizational and ethical issues in VAD use, including the process of patient selection.
Details
Project Status: Completed
Year Published: 2012
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Heart Failure
Contact
Organisation Name: Institut national d'excellence en sante et en services sociaux
Contact Address: L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name: demande@inesss.qc.ca
Contact Email: demande@inesss.qc.ca
Copyright: L'Institut national d'excellence en sante et en services sociaux (INESSS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.